Last updated on May 2020

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Blood Cancer | Breast Cancer - HER2 Positive | Healthy Volunteers | Metastatic Triple-Negative Breast Cancer | Cancer/Tumors | Cancer | Drugs | Neoplasms | Vaginal Atrophy | Diet and Nutrition | Near-Sighted Corrective Surgery | Anal Dysplasia | Chronic Shoulder Pain | Blood disorder | Hematologic Malignancy | Brain Function | Adverse Effects | Injection Port | Hematologic Cancer | Hematological Disorders | Pediatric Health | Ewing's Family Tumors | Hematologic Neoplasms | Recurrent Respiratory Papillomatosis | Peripheral Arterial Occlusive Disease | Cancer (Pediatric) | Primary Immunodeficiency | Razor Bumps (Pseudofolliculitis Barbae) | Chronic Diarrhea | Skin Wounds
  • Age: Between 2 - 110 Years
  • Gender: Male or Female

  • INCLUSION CRITERIA:

The subject carries the diagnosis of malignant solid tumor or a malignant or non-malignant hematologic disorder, and is being screened at the NIH for eligibility for an NIH Clinical Center treatment protocol.

OR

The subject carries the diagnosis of malignant solid tumor or a malignant or non-malignant hematologic disorder, and is already enrolled on a clinical protocol at the NIH Clinical Center.

OR

The subject is a related HLA-compatible family member of a patient (bearing a diagnosis of malignant solid tumor or a malignant or non-malignant hematologic) being evaluated for or already enrolled on a clinical protocol at the NIH Clinical Center and is identified as a potentially suitable donor of allogeneic hematopoietic stem cells for transplantation.

OR

The subject carries the diagnosis of malignant solid tumor or a malignant or non malignant hematologic disorder or a bone marrow failure condition and is not available to participate in an NIH Clinical Center treatment protocol, or travel to the NIH clinical center, but is referred for participation through their home health care provider.

The subject or the subject's guardian is able to understand the investigational nature of the study and provide informed consent after initial counseling by clinical staff. Separate consent forms for all interventional or surgical procedures will be obtained after explanation of the specific procedure.

Age 2 years and older (no upper limit)

EXCLUSION CRITERIA:

Subjects unable to comprehend the investigational nature of the procedure

Age less than 2 years

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.